The clinicians and researchers of the Penn Medicine Bone Marrow and Stem Cell Transplant Program have long been national leaders both in the clinical research and care of patients undergoing transplant as a cancer treatment. Today, there's more hope than ever for those who face a cancer diagnosis in which bone marrow or stem cell transplant is a treatment option.
There are three kinds of bone marrow and stem cell transplantation. An autologous transplant collects the patient's own bone marrow or stem cells before the cancer treatment. After treatment, the collected cells are returned to the patient to replace the cells destroyed by the cancer treatment.
An allogeneic transplant uses donor bone marrow or stem cells to replace the cells destroyed by the cancer treatment. A series of special tests are performed to find a donor who is a match for the patient.
Cord blood transplant removes stem cells from a baby's umbilical cord immediately after being born. The stem cells are stored until they are needed for a transplant. Umbilical cord blood cells are immature and there is less of a concern for them being a match.
A Multidisciplinary Approach to Care
If bone marrow or stem cell transplant is a treatment option for a patient, it's important that patient has the best team of experts available.
With a team of hematologists/oncologists, surgeons, radiation therapists and nutritionists, patients who come to Penn Medicine for their care benefit from a multidisciplinary approach to care. This unique collaboration between disciplines means better outcomes for patients.
Abramson Cancer Center
Services in the Bone Marrow Transplant and Stem Cell Transplant Program
Hematology/oncology services offered within the Bone Marrow and Stem Cell Transplant Program include:
- Autologous and allogenic bone marrow transplants
- Stem cell transplant
- Cord blood transplant
The Penn Difference
- Penn's Bone Marrow and Stem Cell Transplant Program is backed by a premier bone marrow and stem cell transplant research program that continues to make history in the development of new treatments through basic science research and clinical trials.
- Penn Medicine has nationally recognized experts available to provide information, care and support throughout the transplant process.
- Penn's Bone Marrow and Stem Cell Transplant Program is one of the oldest and largest in the country, and has pioneered new therapies to treat blood cancers.
- Penn Medicine has one of the few hematologic malignancy (leukemia, lymphoma and myeloma) research programs in the country that is approved and funded by the National Cancer Institute. It is through this research program that Penn has made significant advances in improving bone marrow and stem cell transplants.
- Penn Medicine has a dedicated hospital unit that is completely equipped to support transplant patients. The unit is staffed by experienced nurses who understand the medical and personal issues patients face during transplant.
- Penn specialists serve as medical advisors for area outreach organizations, such as the Multiple Myeloma Networking Group and the Leukemia and Lymphoma Society. Penn clinicians have received numerous awards for their outstanding patient support activities.
Types of Diseases Treated with Bone Marrow and Stem Cell Transplant
Bone Marrow and Stem Cell Transplant Team
Hematologists/oncologists within the Bone Marrow and Stem Cell Transplant Program include:
Today, more and more people are surviving cancer. It is because of clinical trials, many of which are conducted at Penn Medicine, that patients are benefiting from breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day, giving patients hope that even greater discoveries lie ahead.